219 related articles for article (PubMed ID: 23917726)
21. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
Han YH; Kim SZ; Kim SH; Park WH
Mol Cells; 2008 Aug; 26(2):158-64. PubMed ID: 18596414
[TBL] [Abstract][Full Text] [Related]
22. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation.
Jin HO; Seo SK; Woo SH; Lee HC; Kim ES; Yoo DH; Lee SJ; An S; Choe TB; Kim JI; Hong SI; Rhee CH; Park IC
Lung Cancer; 2008 Sep; 61(3):317-27. PubMed ID: 18281123
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
Vivas-Mejía PE; Ozpolat B; Chen X; Lopez-Berestein G
Int J Cancer; 2009 Jul; 125(2):264-75. PubMed ID: 19408305
[TBL] [Abstract][Full Text] [Related]
24. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
25. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
Liu ZM; Tseng JT; Hong DY; Huang HS
Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of arsenic trioxide-induced apoptosis by 8-bromo-7-methoxychrysin in human leukemia cells involves depletion of intracellular reduced glutathione.
Xiao G; Tang X; Yao C; Wang C
Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):712-21. PubMed ID: 21785114
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
28. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Shen L; Zhang G; Lou Z; Xu G; Zhang G
BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
[TBL] [Abstract][Full Text] [Related]
29. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
Lam SK; Leung LL; Li YY; Zheng CY; Ho JC
Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
[TBL] [Abstract][Full Text] [Related]
30. BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine.
Tanaka Y; Komatsu T; Shigemi H; Yamauchi T; Fujii Y
BMC Cancer; 2014 Jan; 14():27. PubMed ID: 24428916
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide induces apoptosis in human platelets via C-Jun NH2-terminal kinase activation.
Wu Y; Dai J; Zhang W; Yan R; Zhang Y; Ruan C; Dai K
PLoS One; 2014; 9(1):e86445. PubMed ID: 24466103
[TBL] [Abstract][Full Text] [Related]
32. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
[No Abstract] [Full Text] [Related]
33. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
[TBL] [Abstract][Full Text] [Related]
34. Bcl-2 hijacks the arsenic trioxide resistance in SH-SY5Y cells.
Wang J; Peng X; Yang D; Guo M; Xu X; Yin F; Wang Y; Huang J; Zhan L; Qi Z
J Cell Mol Med; 2022 Jan; 26(2):563-569. PubMed ID: 34910369
[TBL] [Abstract][Full Text] [Related]
35. Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
Boyko-Fabian M; Niehr F; Distel L; Budach V; Tinhofer I
PLoS One; 2014; 9(6):e98867. PubMed ID: 24927258
[TBL] [Abstract][Full Text] [Related]
36. Abrogating HSP response augments cell death induced by As2O3 in glioma cell lines.
Song X; Chen Z; Wu C; Zhao S
Can J Neurol Sci; 2010 Jul; 37(4):504-11. PubMed ID: 20724260
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma.
Lam SK; Li YY; Zheng CY; Ho JC
Int J Oncol; 2015 Jan; 46(1):113-22. PubMed ID: 25335113
[TBL] [Abstract][Full Text] [Related]
38. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells.
Yedjou C; Tchounwou P; Jenkins J; McMurray R
J Hematol Oncol; 2010 Aug; 3():28. PubMed ID: 20796291
[TBL] [Abstract][Full Text] [Related]
39. Silencing SATB1 inhibits the malignant phenotype and increases sensitivity of human osteosarcoma U2OS cells to arsenic trioxide.
Zhang H; Su X; Guo L; Zhong L; Li W; Yue Z; Wang X; Mu Y; Li X; Li R; Wang Z
Int J Med Sci; 2014; 11(12):1262-9. PubMed ID: 25317073
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis.
Hyun Park W; Hee Cho Y; Won Jung C; Oh Park J; Kim K; Hyuck Im Y; Lee MH; Ki Kang W; Park K
Biochem Biophys Res Commun; 2003 Jan; 300(1):230-5. PubMed ID: 12480548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]